Freeflow Ventures

About Freeflow Ventures

Freeflow is an early-stage venture firm focused on investing in deep tech solutions for human and planetary health challenges. Launched in 2019, they target high-potential, science-driven companies, particularly those leveraging AI, machine learning, and proprietary IP to bring innovations to market efficiently. Their model emphasizes connecting with founders early, investing at initial stages, and providing support in fundraising, marketing, and strategy.

Products & Services

Investment in Human Health Companies:Invests in companies like Iambic Therapeutics, which uses AI for small-molecule drug discovery, and StrokeDx, which develops non-invasive stroke diagnosis technology.

Investment in Planetary Health Companies:Supports companies like Hydrosat, providing geospatial intelligence via satellite imagery for food security and environment, and Captura, focusing on carbon dioxide capture from ocean water.

Founder Sessions:A content series highlighting origin stories of portfolio company founders to educate and inspire the community.

Specialties

Deep Tech Innovation AI and Machine Learning Human Health Solutions Planetary Health Solutions Early-Stage Investments

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Venture Capital Fund Raise T: - FT: Venture Capital Fund Raise	A: 90000000 MR: - FA: 90 million USD FAN: 90000000	D: 2024-06-28 FD: 2024-06-28	-

Venture Capital Fund Raise Latest

2024-06-28

$90.0M

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

D

David Fleck

Founder & Managing Partner

K

Kevin Barrett

Managing Partner

S

Steve Roy

Operating Partner

A

Adam Wierman

Computer Scientist and Caltech Professor

D

Dave Schaffer

Hubbard Howe Professor of Chemical and Biomolecular Engineering, Bioengineering, and Molecular and Cell Biology at the University of California, Berkeley; Director of QB3, Bakar Labs, and Bakar Fellows Program

B

Barbara Wold

Bren Professor of Molecular Biology at Caltech

View 6 more team members with Pro

Unlock Full Team Directory

Recent News